EP2379057
Fenýlefrínsamsetningar með aukinn stöðugleika
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.12.2009EP published:
17.7.2013EP application number:
09795623.9
EP translation filed:
14.8.2013Grant published:
15.9.2013EPO information:
European Patent Register
Max expiry date:
10.12.2029Expiry date:
10.12.2018
Title:
PHENYLEPHRINE FORMULATIONS WITH IMPROVED STABILITY
Timeline
Today
11.12.2009EP application
17.7.2013EP Publication
14.8.2013Translation submitted
15.9.2013Registration published
10.12.2018Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
DUNGAN, TimothyAddress:
Lincoln, Nebraska, US
Name:
WARRINGTON, BrianAddress:
Lincoln, Nebraska, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
139391 PDate:
19.12.2008Country:
US
Classification
Categories:
A61K 9/20, A61K 31/167, A61K 31/137, A61K 31/135, A61K 31/485, A61K 31/375
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 6.11.2013
Expires: 10.12.2014
Payer: Árnason Faktor
Number: 6
Paid: 7.11.2014
Expires: 10.12.2015
Payer: Árnason Faktor
Number: 7
Paid: 12.11.2015
Expires: 10.12.2016
Payer: Örn Þór, slf.
Number: 8
Paid: 10.11.2016
Expires: 10.12.2017
Payer: Örn Þór, slf.
Number: 9
Paid: 13.11.2017
Expires: 10.12.2018
Payer: Örn Þór, slf.